As of Nov 20, 2026, 1 of 2 active firms rate EXPO a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
EXPO EPS & revenue forecast
EPS · NEXT QUARTER
$0.86
Range $0.86 – $0.86 · 1 analysts · +46% YoY
Next period, 1 analysts expect Exponent Inc to earn $0.86 a share (range $0.86 – $0.86), versus $0.59 a year earlier. Full-year consensus is $2.57, growing to $2.92 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $613.8M, rising to $668.7M next year.
Top analysts covering Exponent Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EXPO.
#1
JC
Joshua Chan
UBS · Rank #274
Neutral
$72.00-19.1% to target
Overall win rate
40%
+ Follow
#2
TS
Tomohiko Sano
JP Morgan
Buy
$90.00+1.1% to target
Coverage
—
+ Follow
#3
Andrew Nicholas
William Blair
Buy
No targeton EXPO
Coverage
—
+ Follow
EXPO stock forecast FAQ
What is EXPO's average 12-month price target?+
The 2 active firms with a live target average $81.00 for Exponent Inc over the next 12 months, ranging from a $90.00 high to a $72.00 low, as of Nov 20, 2026.
Is EXPO stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 20, 2026, 1 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for EXPO?+
The Street-high target is $90.00 (JP Morgan), and the Street-low is $72.00 (UBS). The average of all 2 active-firm targets is $81.00.
How many active Wall Street firms cover EXPO?+
2 active firms have a recognized rating on Exponent Inc as of Nov 20, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering EXPO?+
Among analysts who currently cover EXPO, Joshua Chan of UBS has the strongest overall Quantellect track record (Rank #274). Their current call is Neutral with a $72.00 target.
What is Exponent Inc's projected EPS for next quarter?+
The consensus estimate is $0.86 per share (range $0.86 – $0.86) across 1 analysts. Full-year EPS is projected at $2.57, rising to $2.92 the following year.
How much revenue is Exponent Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $613.8M, growing to $668.7M next year.
Have analysts been upgrading or downgrading EXPO lately?+
As of Nov 20, 2026, 1 of 2 active firms rate EXPO a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EXPO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.